First Approval of Adagrasib for the Treatment of Non-Small Cell Lung Cancer Harboring a KRASG12C Mutation

被引：7
|
作者：
De, Surya K. [1 ,2 ]
机构：
[1] Conju Probe, Dept Chem, San Diego, CA 92121 USA
[2] Bharath Univ, Chennai 600126, Tamil Nadu, India
来源：
CURRENT MEDICINAL CHEMISTRY | 2024年 / 31卷 / 03期
关键词：
Non-small cell lung cancer; KRAS mutation; guanosine triphosphate; guanosine diphosphate; adagrasib; sotorasib; RESISTANCE; RAS;
D O I：
10.2174/0929867330666230330122000
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Adagrasib is an orally bioavailable, highly selective, small-molecule, irreversible covalent inhibitor of KRAS(G12C). It was approved by the US FDA on December 12, 2022, for patients with tumors harboring the KRAS(G12C )mutation in locally advanced or metastatic non-small cell lung cancer (NSCLC). Herein, synthesis, dosage and administration, mechanism of action, pharmacokinetics, pharmacodynamics, and adverse events of adagrasib are described.
引用
收藏
页码：266 / 272
页数：7
相关论文
共 50 条
  • [41] Virtual clinical trial simulations for a novel KRASG12C inhibitor (ASP2453) in non-small cell lung cancer
    Sayama, Hiroyuki
    Marcantonio, Diana
    Nagashima, Takeyuki
    Shimazaki, Masashi
    Minematsu, Tsuyoshi
    Apgar, Joshua F.
    Burke, John M.
    Wille, Lucia
    Nagasaka, Yasuhisa
    Kirouac, Daniel C.
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2021, 10 (08): : 864 - 877
  • [42] Synthesis of Adagrasib (MRTX849), a Covalent KRASG12C Inhibitor Drug for the Treatment of Cancer
    Chen, Cheng-yi
    Lu, Zhichao
    Scattolin, Thomas
    Chen, Chengsheng
    Gan, Yonghong
    McLaughlin, Mark
    ORGANIC LETTERS, 2023, : 944 - 949
  • [43] Therapeutic activity of a new KRASG12C inhibitor JMKX001899 in brain metastases: Preclinical models of KRASG12C-mutant non-small cell lung cancer
    He, Danming
    Wang, Jie
    Zhu, Yixiang
    Zhong, Jia
    Bai, Hua
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [44] Sotorasib plus panitumumab for pre-treated non-small cell lung cancer with KRASG12C mutation: A phase 1b study.
    Langer, Corey J.
    Galot, Rachel
    Prenen, Hans
    Hong, David S.
    Victoria, Ivan
    Salgia, Ravi
    Chenard-Poirier, Maxime
    Furqan, Muhammad
    Chan, Emily
    Nolte-Hippenmeyer, Jane
    Xia, Caihong
    Li, Bob T.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [45] Sotorasib in KRASG12C mutated lung cancer
    Olivier, Timothee
    Prasad, Vinay
    LANCET, 2024, 403 (10422):
  • [46] SOTORASIB IS ACTIVE IN KRASG12C-MUTANT NON-SMALL CELL LUNG CANCER
    Skoulidis, F.
    Li, B. T.
    Dy, G. K.
    Price, T. J.
    Falchook, G. S.
    Wolf, J.
    CANCER DISCOVERY, 2021, 11 (08) : 1870 - 1870
  • [47] KRYSTAL-1: Activity and safety of adagrasib (MRTX849) in patients with advanced solid tumors harboring a KRASG12C mutation
    Pant, Shubham
    Yaeger, Rona
    Spira, Alexander I.
    Pelster, Meredith
    Sabari, Joshua K.
    Hafez, Navid
    Barve, Minal A.
    Velastegui, Karen
    Yan, Xiaohong
    Der-Torossian, Hirak
    Bekaii-Saab, Tanios S.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (36_SUPPL) : 425082 - 425082
  • [48] Rapid autopsy provides unique research opportunity to evaluate KRASG12C inhibitor resistance mechanisms in non-small cell lung cancer
    Ozakinci, Hilal
    Nazario, Gina
    Stern, Yaakov
    Solanki, Hitendra S.
    Chen, Dung-Tsa
    Trevor, Rose
    Schabath, Matthew
    Stewart, Paul
    Teer, Jamie K.
    Beg, Amer
    Boyle, Theresa A.
    Haura, Eric
    Pellini, Bruna
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [49] CRISPR Screening Identifies Mechanisms of Resistance to KRASG12C and SHP2 Inhibitor Combinations in Non-Small Cell Lung Cancer
    Prahallad, Anirudh
    Weiss, Andreas
    Voshol, Hans
    Kerr, Grainne
    Sprouffske, Kathleen
    Yuan, Tina
    Ruddy, David
    Meistertzheim, Morgane
    Kazic-Legueux, Malika
    Kottarathil, Tina
    Piquet, Michelle
    Cao, Yichen
    Martinuzzi-Duboc, Laetitia
    Buhles, Alexandra
    Adler, Flavia
    Mannino, Salvatore
    Tordella, Luca
    Sansregret, Laurent
    Maira, Sauveur-Michel
    Graus Porta, Diana
    Fedele, Carmine
    Brachmann, Saskia M.
    CANCER RESEARCH, 2023, 83 (24) : 4130 - 4141
  • [50] Adagrasib Treatment After Sotorasib-Related Hepatotoxicity in Patients With KRASG12C-Mutated Non-Small Cell Lung Cancer: A Case Series and Literature Review
    Luo, Jia
    Florez, Narjust
    Donnelly, Anjali
    Lou, Yanyan
    Lu, Kevin
    Ma, Patrick C.
    Spira, Alexander I.
    Ryan, Debra
    Husain, Hatim
    JCO PRECISION ONCOLOGY, 2024, 8
12345